<DOC>
	<DOCNO>NCT01620788</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy indapamide 1.5mg / losartan 50mg indapamide 1.5mg / losartan 100mg reduction blood pressure .</brief_summary>
	<brief_title>Comparison Losartan Associated With Indapamide Versus Hyzaar® Hypertension Treatment</brief_title>
	<detailed_description>- open label , randomize , multicenter - Experiment duration : 12 week . - 05 visit ( day 0 - randomization ) , ( day 1 - 2 week pos-randomization ) , ( day 2 - 4 week pos-randomization ) , ( day 3 - 8 week pos-randomization ) ( day 4 - 12 week pos-randomization ) . - evaluate efficacy medication associate two antihypertensive agent two fixed dos compare Hyzaar® patient hypertension - Adverse event evaluation</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Indapamide</mesh_term>
	<criteria>Adults male female age ≥ 18 year old ; Patients diagnosis Hypertension ( define medical investigator ) treat monotherapy least two blood pressure measurement ≥ 140/90 , sit position 5 ' interval measurement , Patients normal lab test result last six month investigator consider clinically significant , Patient accept discontinuation previous hypertension therapy . Patients blood pressure ≥ 180/100 mmHg ; Patients uncontrolled hypertension ( ≥ 140/90 mmHg ) treat thiazide diuretic ; Presence concomitant coronary artery disease , congestive heart failure , diabetes renal failure ( creatinine &gt; 1.5 mg / dL ) ; Patients hypo hyperkalemia ( serum potassium outside normal range ) ; Patients ALT great 2.5 upper limit normal active liver disease ; Pregnant woman , woman childbearing age use effective contraception intend become pregnant study period ; Patients drug alcohol abuse last two year ; Patients secondary hypertension ( renovascular disease , pheochromocytoma , Cushing 's syndrome ) ; Patients allergic reaction hypersensitivity ACE inhibitor , diuretic medication contain sulfa / excipients formulation ; Refusal inability provide Informed Consent Term . ; Refusal discontinue antihypertensive medication . Patients discretion investigator indication discontinue current medication ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>